Bayer’s $62 billion bid for Monsanto, as of this writing, has been rejected, but both parties say they are continuing to negotiate.
Concentration in corporate power is the defining feature of today's global economy, with profound implications for livelihoods, well-being, the environment and human rights. ETC Group has long monitored the "Gene Giants" (who aggregate control over seeds, agrochemicals, pharmaceuticals, biotechnology, genomics and food processing and retailing). Today many of the same large corporations are touting the use of new technologies - including genomics, nanotechnology and synthetic biology - to transform biomass into high-value products or to manufacture materials "from the bottom up." They are moving from being - 'gene giants' to 'biomass-ters' or even 'matter moguls.'